» Articles » PMID: 39076191

Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications

Overview
Date 2024 Jul 30
PMID 39076191
Authors
Affiliations
Soon will be listed here.
Abstract

Despite ischemic heart disease (IHD) has been commonly identified as the consequence of obstructive coronary artery disease (OCAD), a significant percentage of patients undergoing coronary angiography because of signs and/or symptoms of myocardial ischemia do not have any significant coronary artery stenosis. Several mechanisms other than coronary atherosclerosis, including coronary microvascular dysfunction (CMD), coronary endothelial dysfunction and epicardial coronary vasospasm, can determine myocardial ischemia or even myocardial infarction in the absence of flow-limiting epicardial coronary stenosis, highlighting the need of performing adjunctive diagnostic tests at the time of coronary angiography to achieve a correct diagnosis. This review provides updated evidence of the pathophysiologic mechanisms of myocardial ischemia with non-obstructive coronary arteries, focusing on the diagnostic and therapeutic implications of performing a comprehensive invasive functional evaluation consisting of the assessment of both vasodilation and vasoconstriction disorders. Moreover, performing a comprehensive invasive functional assessment may have important prognostic and therapeutic implications both in patients presenting with myocardial ischemia with non-obstructive coronary arteries (INOCA) or myocardial infarction with non-obstructive coronary arteries (MINOCA), as the implementation of a tailored patient management demonstrated to improve patient's symptoms and prognosis. However, given the limited knowledge of myocardial ischaemia with non-obstructive coronary arteries, there are no specific therapeutic interventions for these patients, and further research is warranted aiming to elucidate the underlying mechanisms and risk factors and to develop personalized forms of treatment.

Citing Articles

MINOCA Associated with a Myocardial Bridge: Pathogenesis, Diagnosis and Treatment.

Rinaldi R, Princi G, La Vecchia G, Bonanni A, Chiariello G, Candreva A J Clin Med. 2023; 12(11).

PMID: 37297993 PMC: 10253711. DOI: 10.3390/jcm12113799.

References
1.
Pepine C, Anderson R, Sharaf B, Reis S, Smith K, Handberg E . Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010; 55(25):2825-32. PMC: 2898523. DOI: 10.1016/j.jacc.2010.01.054. View

2.
Del Buono M, Montone R, Iannaccone G, Meucci M, Rinaldi R, DAmario D . Diagnostic work-up and therapeutic implications in MINOCA: need for a personalized approach. Future Cardiol. 2020; 17(1):149-154. DOI: 10.2217/fca-2020-0052. View

3.
Handberg E, Merz C, Cooper-DeHoff R, Wei J, Conlon M, Lo M . Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. Am Heart J. 2021; 237:90-103. DOI: 10.1016/j.ahj.2021.03.011. View

4.
Kosugi M, Nakagomi A, Shibui T, Kato K, Kusama Y, Atarashi H . Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina. Circ J. 2011; 75(9):2196-205. DOI: 10.1253/circj.cj-11-0056. View

5.
Planer D, Mehran R, Ohman E, White H, Newman J, Xu K . Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv. 2014; 7(3):285-93. DOI: 10.1161/CIRCINTERVENTIONS.113.000606. View